W Health Ventures is a healthcare company-creation and venture investment platform building businesses in India and the US–India corridor. Its physicians, operators and technologists research gaps in healthcare delivery, validate solutions with patients, recruit founding teams and provide initial capital and operating support from the pre-idea stage. Its companies span mental health, chronic pain, metabolic care, oncology, pediatrics and healthcare AI and engineering. Everbright Health supports US psychiatry practices delivering advanced interventions for treatment-resistant depression, while Wysa is an AI-guided mental-health investment. W Health Ventures Fund II is managed by W Health Ventures Investment Advisors LLP, the investment manager named in its Indian Category II AIF disclosure. The public directory distinguishes its operating team from external advisors.
Founded
—
Type
Venture capital
Funds1
W Health Ventures Fund II₹7B
An Indian Category II healthcare company-creation fund managed by W Health Ventures Investment Advisors LLP. The fund closed at INR700 crore, above its INR630 crore target, to build 8–10 companies over four years from pre-idea to category leadership. It applies physician, operator and technology expertise to gaps in healthcare delivery in India and the US–India corridor. The issuer names Everhope Oncology and Everbright Health as its first two companies. September9,2026 is the verified managing-partner announcement date; the original own press-release page does not publish an exact legal-close day.